These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9072299)

  • 1. [Neurologic diseases and chromosome 17].
    Nevsímalová S
    Cas Lek Cesk; 1996 Dec; 135(24):799-802. PubMed ID: 9072299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of hereditary neuropathies.
    Chance PF
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies.
    Silander K; Meretoja P; Juvonen V; Ignatius J; Pihko H; Saarinen A; Wallden T; Herrgård E; Aula P; Savontaus ML
    Hum Mutat; 1998; 12(1):59-68. PubMed ID: 9633821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
    Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
    J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1.
    Numakura C; Lin C; Oka N; Akiguchi I; Hayasaka K
    Ann Neurol; 2000 Jan; 47(1):101-3. PubMed ID: 10632107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
    Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
    J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
    Roa BB; Garcia CA; Lupski JR
    Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
    Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
    Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; Charcot-Marie-Tooth disease or the hereditary motor and sensory neuropathies].
    Verhamme C; Baas F
    Ned Tijdschr Geneeskd; 2005 Jul; 149(27):1505-9. PubMed ID: 16032995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of hereditary neuropathy with liability to pressure palsies.
    Chance PF
    Ann N Y Acad Sci; 1999 Sep; 883():14-21. PubMed ID: 10586225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
    Naef R; Suter U
    Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions leading to HMSN/HNPP.
    Thiel CT; Kraus C; Rauch A; Ekici AB; Rautenstrauss B; Reis A
    Eur J Hum Genet; 2003 Feb; 11(2):170-8. PubMed ID: 12634865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families.
    Mostacciuolo ML; Righetti E; Zortea M; Bosello V; Schiavon F; Vallo L; Merlini L; Siciliano G; Fabrizi GM; Rizzuto N; Milani M; Baratta S; Taroni F
    Hum Mutat; 2001; 18(1):32-41. PubMed ID: 11438991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA
    Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Charcot-Marie-Tooth disease type 1A.
    Thomas PK
    Ann N Y Acad Sci; 1999 Sep; 883():1-5. PubMed ID: 10586223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary electrophoresis for the detection of PMP22 gene duplication: study in Mexican patients.
    Hernández-Zamora E; de la Luz Arenas-Sordo M; Maldonado-Rodríguez R
    Electrophoresis; 2008 Apr; 29(7):1582-4. PubMed ID: 18318003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update on hereditary neuropathy].
    Nakagawa M; Takashima H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):991-4. PubMed ID: 15651351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.